AC-3174

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameAC-3174
Drug Alias Name(Leu14)exendin-4[14-Leu]exendin-4glucagon-like peptide-1 receptor agonist (Amylin Pharmaceuticals)GLP-1 agonist (Amylin Pharmaceuticals)AC-3174
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionGlucagon-like peptide 1 receptor agonists
TargetsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsObesityDiabetes Mellitus, Type 2Metabolic Dysfunction-Associated Steatotic Liver Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAmylin Pharmaceuticals Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAmylin Pharmaceuticals LlcAstrazeneca Plc
Active IndicationsN/A
Inactive IndicationsObesityDiabetes Mellitus, Type 2Metabolic Dysfunction-Associated Steatotic Liver Disease

Other Information

ATC CodeN/A
Related LinksN/A